 | • レポートコード：MRC2102QY9396 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のムコ多糖症II型市場について種類別（JR-141、EGT-301、DUOC-01、AGT-182、JR-032、その他）、用途別（病院、クリニック、研究センター、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ムコ多糖症II型市場の概要 ・世界の主要地域別ムコ多糖症II型市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のムコ多糖症II型市場規模2015-2026：種類別（JR-141、EGT-301、DUOC-01、AGT-182、JR-032、その他） ・世界のムコ多糖症II型市場規模2015-2026：用途別（病院、クリニック、研究センター、その他） ・ムコ多糖症II型の米国市場規模2015-2020 ・ムコ多糖症II型のヨーロッパ市場規模2015-2020 ・ムコ多糖症II型の中国市場規模2015-2020 ・ムコ多糖症II型の日本市場規模2015-2020 ・ムコ多糖症II型の東南アジア市場規模2015-2020 ・ムコ多糖症II型のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ムコ多糖症II型の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ムコ多糖症II型の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Mucopolysaccharidosis II Market
The global Mucopolysaccharidosis II market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Mucopolysaccharidosis II Scope and Market Size
The global Mucopolysaccharidosis II market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mucopolysaccharidosis II market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Mucopolysaccharidosis II market is segmented into
JR-141
EGT-301
DUOC-01
AGT-182
JR-032
Others
Segment by Application, the Mucopolysaccharidosis II market is segmented into
Hospital
Clinic
Research Center
Others
The Mucopolysaccharidosis II market is analysed and market size information is provided by regions (countries). Segment by Application, the Mucopolysaccharidosis II market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Mucopolysaccharidosis II Market Share Analysis
Mucopolysaccharidosis II market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Mucopolysaccharidosis II business, the date to enter into the Mucopolysaccharidosis II market, Mucopolysaccharidosis II product introduction, recent developments, etc.
The major vendors covered:
Alexion Pharmaceuticals, Inc.
AngioChem Inc.
ArmaGen Inc.
Bioasis Technologies Inc.
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co., Ltd.
Laboratorios Del Dr. Esteve S.A.
RegenxBio Inc.
Sangamo BioSciences, Inc.
Takeda
1 Mucopolysaccharidosis II Market Overview
1.1 Mucopolysaccharidosis II Product Scope
1.2 Mucopolysaccharidosis II Segment by Type
1.2.1 Global Mucopolysaccharidosis II Sales by Type (2020-2026)
1.2.2 JR-141
1.2.3 EGT-301
1.2.4 DUOC-01
1.2.5 AGT-182
1.2.6 JR-032
1.2.7 Others
1.3 Mucopolysaccharidosis II Segment by Application
1.3.1 Global Mucopolysaccharidosis II Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Others
1.4 Mucopolysaccharidosis II Market Estimates and Forecasts (2015-2026)
1.4.1 Global Mucopolysaccharidosis II Sales Growth Rate (2015-2026)
1.4.2 Global Mucopolysaccharidosis II Revenue and Growth Rate (2015-2026)
1.4.3 Global Mucopolysaccharidosis II Price Trends (2015-2026)
2 Mucopolysaccharidosis II Estimate and Forecast by Region
2.1 Global Mucopolysaccharidosis II Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Mucopolysaccharidosis II Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Mucopolysaccharidosis II Sales Market Share by Region (2015-2020)
2.2.2 Global Mucopolysaccharidosis II Revenue Market Share by Region (2015-2020)
2.3 Global Mucopolysaccharidosis II Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Mucopolysaccharidosis II Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Mucopolysaccharidosis II Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Mucopolysaccharidosis II Estimates and Projections (2015-2026)
2.4.2 Europe Mucopolysaccharidosis II Estimates and Projections (2015-2026)
2.4.3 China Mucopolysaccharidosis II Estimates and Projections (2015-2026)
2.4.4 Japan Mucopolysaccharidosis II Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Mucopolysaccharidosis II Estimates and Projections (2015-2026)
2.4.6 India Mucopolysaccharidosis II Estimates and Projections (2015-2026)
3 Global Mucopolysaccharidosis II Competition Landscape by Players
3.1 Global Top Mucopolysaccharidosis II Players by Sales (2015-2020)
3.2 Global Top Mucopolysaccharidosis II Players by Revenue (2015-2020)
3.3 Global Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucopolysaccharidosis II as of 2019)
3.4 Global Mucopolysaccharidosis II Average Price by Company (2015-2020)
3.5 Manufacturers Mucopolysaccharidosis II Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Mucopolysaccharidosis II Players (Opinion Leaders)
4 Global Mucopolysaccharidosis II Market Size by Type
4.1 Global Mucopolysaccharidosis II Historic Market Review by Type (2015-2020)
4.1.1 Global Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
4.1.2 Global Mucopolysaccharidosis II Revenue Market Share by Type (2015-2020)
4.1.3 Global Mucopolysaccharidosis II Price by Type (2015-2020)
4.2 Global Mucopolysaccharidosis II Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Mucopolysaccharidosis II Sales Forecast by Type (2021-2026)
4.2.2 Global Mucopolysaccharidosis II Revenue Forecast by Type (2021-2026)
4.2.3 Global Mucopolysaccharidosis II Price Forecast by Type (2021-2026)
5 Global Mucopolysaccharidosis II Market Size by Application
5.1 Global Mucopolysaccharidosis II Historic Market Review by Application (2015-2020)
5.1.1 Global Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
5.1.2 Global Mucopolysaccharidosis II Revenue Market Share by Application (2015-2020)
5.1.3 Global Mucopolysaccharidosis II Price by Application (2015-2020)
5.2 Global Mucopolysaccharidosis II Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Mucopolysaccharidosis II Sales Forecast by Application (2021-2026)
5.2.2 Global Mucopolysaccharidosis II Revenue Forecast by Application (2021-2026)
5.2.3 Global Mucopolysaccharidosis II Price Forecast by Application (2021-2026)
6 United States Mucopolysaccharidosis II Market Facts & Figures
6.1 United States Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
6.2 United States Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
6.3 United States Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
7 Europe Mucopolysaccharidosis II Market Facts & Figures
7.1 Europe Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
7.2 Europe Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
7.3 Europe Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
8 China Mucopolysaccharidosis II Market Facts & Figures
8.1 China Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
8.2 China Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
8.3 China Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
9 Japan Mucopolysaccharidosis II Market Facts & Figures
9.1 Japan Mucopolysaccharidosis II Sales Market Share by Company (3015-3030)
9.2 Japan Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
9.3 Japan Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
10 Southeast Asia Mucopolysaccharidosis II Market Facts & Figures
10.1 Southeast Asia Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
11 India Mucopolysaccharidosis II Market Facts & Figures
11.1 India Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
11.2 India Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
11.3 India Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Mucopolysaccharidosis II Business
12.1 Alexion Pharmaceuticals, Inc.
12.1.1 Alexion Pharmaceuticals, Inc. Corporation Information
12.1.2 Alexion Pharmaceuticals, Inc. Business Overview
12.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Products Offered
12.1.5 Alexion Pharmaceuticals, Inc. Recent Development
12.2 AngioChem Inc.
12.2.1 AngioChem Inc. Corporation Information
12.2.2 AngioChem Inc. Business Overview
12.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AngioChem Inc. Mucopolysaccharidosis II Products Offered
12.2.5 AngioChem Inc. Recent Development
12.3 ArmaGen Inc.
12.3.1 ArmaGen Inc. Corporation Information
12.3.2 ArmaGen Inc. Business Overview
12.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ArmaGen Inc. Mucopolysaccharidosis II Products Offered
12.3.5 ArmaGen Inc. Recent Development
12.4 Bioasis Technologies Inc.
12.4.1 Bioasis Technologies Inc. Corporation Information
12.4.2 Bioasis Technologies Inc. Business Overview
12.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Products Offered
12.4.5 Bioasis Technologies Inc. Recent Development
12.5 Green Cross Corporation
12.5.1 Green Cross Corporation Corporation Information
12.5.2 Green Cross Corporation Business Overview
12.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Green Cross Corporation Mucopolysaccharidosis II Products Offered
12.5.5 Green Cross Corporation Recent Development
12.6 Inventiva
12.6.1 Inventiva Corporation Information
12.6.2 Inventiva Business Overview
12.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Inventiva Mucopolysaccharidosis II Products Offered
12.6.5 Inventiva Recent Development
12.7 JCR Pharmaceuticals Co., Ltd.
12.7.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
12.7.2 JCR Pharmaceuticals Co., Ltd. Business Overview
12.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.7.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Products Offered
12.7.5 JCR Pharmaceuticals Co., Ltd. Recent Development
12.8 Laboratorios Del Dr. Esteve S.A.
12.8.1 Laboratorios Del Dr. Esteve S.A. Corporation Information
12.8.2 Laboratorios Del Dr. Esteve S.A. Business Overview
12.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Products Offered
12.8.5 Laboratorios Del Dr. Esteve S.A. Recent Development
12.9 RegenxBio Inc.
12.9.1 RegenxBio Inc. Corporation Information
12.9.2 RegenxBio Inc. Business Overview
12.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.9.4 RegenxBio Inc. Mucopolysaccharidosis II Products Offered
12.9.5 RegenxBio Inc. Recent Development
12.10 Sangamo BioSciences, Inc.
12.10.1 Sangamo BioSciences, Inc. Corporation Information
12.10.2 Sangamo BioSciences, Inc. Business Overview
12.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Products Offered
12.10.5 Sangamo BioSciences, Inc. Recent Development
12.11 Takeda
12.11.1 Takeda Corporation Information
12.11.2 Takeda Business Overview
12.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Takeda Mucopolysaccharidosis II Products Offered
12.11.5 Takeda Recent Development
13 Mucopolysaccharidosis II Manufacturing Cost Analysis
13.1 Mucopolysaccharidosis II Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Mucopolysaccharidosis II
13.4 Mucopolysaccharidosis II Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Mucopolysaccharidosis II Distributors List
14.3 Mucopolysaccharidosis II Customers
15 Market Dynamics
15.1 Mucopolysaccharidosis II Market Trends
15.2 Mucopolysaccharidosis II Opportunities and Drivers
15.3 Mucopolysaccharidosis II Market Challenges
15.4 Mucopolysaccharidosis II Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Mucopolysaccharidosis II Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Mucopolysaccharidosis II Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Mucopolysaccharidosis II Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Mucopolysaccharidosis II Sales (K Pcs) by Region (2015-2020)
Table 5. Global Mucopolysaccharidosis II Sales Market Share by Region (2015-2020)
Table 6. Global Mucopolysaccharidosis II Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Mucopolysaccharidosis II Revenue Share by Region (2015-2020)
Table 8. Global Mucopolysaccharidosis II Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Mucopolysaccharidosis II Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Mucopolysaccharidosis II Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Mucopolysaccharidosis II Revenue Share Forecast by Region (2021-2026)
Table 12. Global Mucopolysaccharidosis II (K Pcs) of Key Companies (2015-2020)
Table 13. Global Mucopolysaccharidosis II Sales Share by Company (2015-2020)
Table 14. Global Mucopolysaccharidosis II Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Mucopolysaccharidosis II Revenue Share by Company (2015-2020)
Table 16. Global Mucopolysaccharidosis II by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucopolysaccharidosis II as of 2019)
Table 17. Global Mucopolysaccharidosis II Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Mucopolysaccharidosis II Manufacturing Sites and Area Served
Table 19. Manufacturers Mucopolysaccharidosis II Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Mucopolysaccharidosis II Players
Table 22. Global Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 23. Global Mucopolysaccharidosis II Sales Share by Type (2015-2020)
Table 24. Global Mucopolysaccharidosis II Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Mucopolysaccharidosis II Price (K Pcs) by Type (2015-2020)
Table 26. Global Mucopolysaccharidosis II Sales Share by Type (2021-2026)
Table 27. Global Mucopolysaccharidosis II Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Mucopolysaccharidosis II Revenue Share by Type (2021-2026)
Table 29. Global Mucopolysaccharidosis II Price (K Pcs) by Type (2021-2026)
Table 30. Global Mucopolysaccharidosis II Sales (K Pcs) by Application (2015-2020)
Table 31. Global Mucopolysaccharidosis II Sales Share by Application (2015-2020)
Table 32. Global Mucopolysaccharidosis II Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Mucopolysaccharidosis II Price (K Pcs) by Application (2015-2020)
Table 34. Global Mucopolysaccharidosis II Sales (K Pcs) by Application (2021-2026)
Table 35. Global Mucopolysaccharidosis II Sales Share by Application (2021-2026)
Table 36. Global Mucopolysaccharidosis II Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Mucopolysaccharidosis II Revenue Share by Application (2021-2026)
Table 38. Global Mucopolysaccharidosis II Price (K Pcs) by Application (2021-2026)
Table 39. United States Mucopolysaccharidosis II Sales (K Pcs) by Company (2015-2020)
Table 40. United States Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
Table 41. United States Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 42. United States Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
Table 43. United States Mucopolysaccharidosis II Sales (K Pcs) by Application (2015-2020)
Table 44. United States Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
Table 45. Europe Mucopolysaccharidosis II Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
Table 47. Europe Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
Table 49. Europe Mucopolysaccharidosis II Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
Table 51. China Mucopolysaccharidosis II Sales (K Pcs) by Company (2015-2020)
Table 52. China Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
Table 53. China Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 54. China Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
Table 55. China Mucopolysaccharidosis II Sales (K Pcs) by Application (2015-2020)
Table 56. China Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
Table 57. Japan Mucopolysaccharidosis II Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
Table 59. Japan Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
Table 61. Japan Mucopolysaccharidosis II Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Mucopolysaccharidosis II Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
Table 69. India Mucopolysaccharidosis II Sales (K Pcs) by Company (2015-2020)
Table 70. India Mucopolysaccharidosis II Sales Market Share by Company (2015-2020)
Table 71. India Mucopolysaccharidosis II Sales (K Pcs) by Type (2015-2020)
Table 72. India Mucopolysaccharidosis II Sales Market Share by Type (2015-2020)
Table 73. India Mucopolysaccharidosis II Sales (K Pcs) by Application (2015-2020)
Table 74. India Mucopolysaccharidosis II Sales Market Share by Application (2015-2020)
Table 75. Alexion Pharmaceuticals, Inc. Corporation Information
Table 76. Alexion Pharmaceuticals, Inc. Description and Business Overview
Table 77. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product
Table 79. Alexion Pharmaceuticals, Inc. Recent Development
Table 80. AngioChem Inc. Corporation Information
Table 81. AngioChem Inc. Description and Business Overview
Table 82. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. AngioChem Inc. Mucopolysaccharidosis II Product
Table 84. AngioChem Inc. Recent Development
Table 85. ArmaGen Inc. Corporation Information
Table 86. ArmaGen Inc. Description and Business Overview
Table 87. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. ArmaGen Inc. Mucopolysaccharidosis II Product
Table 89. ArmaGen Inc. Recent Development
Table 90. Bioasis Technologies Inc. Corporation Information
Table 91. Bioasis Technologies Inc. Description and Business Overview
Table 92. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Bioasis Technologies Inc. Mucopolysaccharidosis II Product
Table 94. Bioasis Technologies Inc. Recent Development
Table 95. Green Cross Corporation Corporation Information
Table 96. Green Cross Corporation Description and Business Overview
Table 97. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Green Cross Corporation Mucopolysaccharidosis II Product
Table 99. Green Cross Corporation Recent Development
Table 100. Inventiva Corporation Information
Table 101. Inventiva Description and Business Overview
Table 102. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Inventiva Mucopolysaccharidosis II Product
Table 104. Inventiva Recent Development
Table 105. JCR Pharmaceuticals Co., Ltd. Corporation Information
Table 106. JCR Pharmaceuticals Co., Ltd. Description and Business Overview
Table 107. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product
Table 109. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 110. Laboratorios Del Dr. Esteve S.A. Corporation Information
Table 111. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Laboratorios Del Dr. Esteve S.A. Description and Business Overview
Table 113. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product
Table 114. Laboratorios Del Dr. Esteve S.A. Recent Development
Table 115. RegenxBio Inc. Corporation Information
Table 116. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. RegenxBio Inc. Description and Business Overview
Table 118. RegenxBio Inc. Mucopolysaccharidosis II Product
Table 119. RegenxBio Inc. Recent Development
Table 120. Sangamo BioSciences, Inc. Corporation Information
Table 121. Sangamo BioSciences, Inc. Description and Business Overview
Table 122. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product
Table 124. Sangamo BioSciences, Inc. Recent Development
Table 125. Takeda Corporation Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Takeda Mucopolysaccharidosis II Product
Table 129. Takeda Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Mucopolysaccharidosis II Distributors List
Table 133. Mucopolysaccharidosis II Customers List
Table 134. Mucopolysaccharidosis II Market Key Trends
Table 135. Mucopolysaccharidosis II Key Opportunities and Drivers
Table 136. Mucopolysaccharidosis II Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Mucopolysaccharidosis II Product Picture
Figure 2. Global Mucopolysaccharidosis II Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Mucopolysaccharidosis II Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Research Center Examples
Figure 9. Others Examples
Figure 10. Global Mucopolysaccharidosis II Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Mucopolysaccharidosis II Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Mucopolysaccharidosis II Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Mucopolysaccharidosis II Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Mucopolysaccharidosis II Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Mucopolysaccharidosis II Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Mucopolysaccharidosis II Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Mucopolysaccharidosis II Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Mucopolysaccharidosis II Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Mucopolysaccharidosis II Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Mucopolysaccharidosis II Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Mucopolysaccharidosis II Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Mucopolysaccharidosis II Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Mucopolysaccharidosis II Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Mucopolysaccharidosis II Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Mucopolysaccharidosis II Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Mucopolysaccharidosis II Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Mucopolysaccharidosis II Players Market Share by Revenue in Mucopolysaccharidosis II 2015 & 2019
Figure 28. Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Mucopolysaccharidosis II Revenue Share by Type (2015-2020)
Figure 30. Global Mucopolysaccharidosis II Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Mucopolysaccharidosis II Revenue Share by Application (2015-2020)
Figure 32. Global Mucopolysaccharidosis II Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Mucopolysaccharidosis II Sales Market Share by Type in 2019
Figure 34. United States Mucopolysaccharidosis II Sales Market Share by Type in 2019
Figure 35. Europe Mucopolysaccharidosis II Sales Market Share by Company in 2019
Figure 36. Europe Mucopolysaccharidosis II Sales Market Share by Type in 2019
Figure 37. Europe Mucopolysaccharidosis II Sales Market Share by Application in 2019
Figure 38. China Mucopolysaccharidosis II Sales Market Share by Company in 2019
Figure 39. China Mucopolysaccharidosis II Sales Market Share by Type in 2019
Figure 40. China Mucopolysaccharidosis II Sales Market Share by Application in 2019
Figure 41. Japan Mucopolysaccharidosis II Sales Market Share by Company in 2019
Figure 42. Japan Mucopolysaccharidosis II Sales Market Share by Type in 2019
Figure 43. Japan Mucopolysaccharidosis II Sales Market Share by Application in 2019
Figure 44. Southeast Asia Mucopolysaccharidosis II Sales Market Share by Company in 2019
Figure 45. Southeast Asia Mucopolysaccharidosis II Sales Market Share by Type in 2019
Figure 46. Southeast Asia Mucopolysaccharidosis II Sales Market Share by Application in 2019
Figure 47. India Mucopolysaccharidosis II Sales Market Share by Company in 2019
Figure 48. India Mucopolysaccharidosis II Sales Market Share by Type in 2019
Figure 49. India Mucopolysaccharidosis II Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Mucopolysaccharidosis II
Figure 52. Manufacturing Process Analysis of Mucopolysaccharidosis II
Figure 53. Mucopolysaccharidosis II Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
自動車用センターキャップの世界市場レポート2020 Market Analysis and Insights: Global Automotive Center Caps Market The global Automotive Center Caps market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Automotive Center Caps Scope and Market Size The global Automotive Cen…- データセンターホワイトボックスサーバーの世界市場レポート2020 Market Analysis and Insights: Global Data Center White Box Server Market The global Data Center White Box Server market size is projected to reach US$ 41770 million by 2026, from US$ 21910 million in 2020, at a CAGR of 11.4% during 2021-2026. Global Data Center White Box Server Scope and Market Size…
- OCC（オフィスコールセンター）ヘッドホンの世界市場レポート2020 Market Analysis and Insights: Global OCC(Office Call Center) Headphone Market The global OCC(Office Call Center) Headphone market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global OCC(Office Call Center) Headphone Scope and Mark…
- 外来手術センターの世界市場レポート2020 Ambulatory Surgery Centers—known as ASCs—are modern health care facilities focused on providing same-day surgical care, including diagnostic and preventive procedures. An ambulatory surgery center is a specialized outpatient facility where patients undergo surgical procedures without having to be ad…
- データセンター光配線盤の世界市場レポート2020 Optical Distribution Frame (Fibre Distribution Frame) is a wiring connection device between optical cable and optical communication equipment or optical communication equipment, which can integrate fiber fuses, fiber terminals, fiber adapters and connectors, and cable connections into a single unit.…